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ABSTRACT
The current study takes an initial step toward deriving a method for empirically based,
theory-driven treatment matching in a military population suffering from PTSD. Along with the
more overt symptoms of PTSD (e.g., persistent hyperarousal), secondary cognitive symptoms
have also been shown to be significantly associated with avoidance and intrusive symptoms, as
well as contribute to functional impairment. Based on the factor analytic and treatment literature
for PTSD, it appears that there are two central mechanisms associated with beneficial therapeutic
change that underlies both CPT and PE treatments (i.e., habituation, changes in cognitions).
Additionally, different traumatic events and peritraumatic responses may be associated with
unique symptom profiles and may necessitate targeted treatment. The present study proposes a
novel approach to treatment matching based on the factor structure of PTSD and underlying
mechanisms of treatment response. More broadly, this paper provides evidence for a broader
understanding of peritraumatic responses and the potential implications of these responses for
symptom profiles and illness trajectories.
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CHAPTER ONE: INTRODUCTION
Armed-service members are subjected to a wide array of potentially traumatic events
(Hoge et al., 2004; Litz et al., 2009), and exhibit varying peritraumtic responses (Brewin et al.,
2000) that may be associated with different clinical presentations and symptom profiles. For
example, traumatic experiences characterized by prolonged/unexpected feelings of helplessness
(e.g., IED explosion, direct gun fire) may lead to a distinctly different subset of symptoms than
traumas associated with guilt/shame (e.g., witnessing the death of a fellow soldier, harming a
child). Researchers have attempted to devise methods to categorize types of traumatic events
(Litz et al., 2009) and match these events to specific symptoms (Stein et al., 2012). For example,
Stein and colleagues (2012) found that events related to “moral injury” (i.e., events that were incontrast with the individuals self-schema) predicted re-experiencing and guilt symptoms,
whereas trauma related to the aftermath of violence predicted negative cognitions about the
world. However, the type of trauma the individual experiences may not be as relevant to
treatment as the symptom profile the event elicits.
Based on the PTSD treatment literature, sustained peritraumatic hyperarousal and the
formation of persistent negative cognitions have been identified as two distinct, but potentially
co-occurring, maladaptive patterns of responding to a traumatic event. These response patterns
have been identified as primary sources of functional impairment (Resick & Miller, 2009) and
potential targets of therapeutic interventions. Despite the clinical utility of conceptualizing PTSD
in these terms, physiological and cognitive symptom clusters have never previously been subject
to confirmatory factor analysis. This is likely because traditionally, CFA is used to identify the
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factors that comprise the construct of PTSD to assist in theorizing about the origins, prevention,
and treatment of the disorder. However, Marshall and colleagues (Marshall et al., 2013) have
stated that it is unlikely that one model of PTSD will emerge that best characterizes maladaptive
responding to traumatic events. Instead, Marshall and colleagues recommended devising models
that are useful for specific purposes. The present confirmatory factor analysis (CFA) aims to
devise a method for treatment matching based on the PTSD treatment literature and, specifically,
existing factor analytic studies regarding PTSD, which have been the subject of considerable
debate.
Currently, the DSM-5 criteria for PTSD (see Table 1) are comprised of four main
symptom categories (i.e., intrusive, avoidance, negative cognitive/mood, and hyperarousal)
(American Psychiatric Association, 2013). Although there is support for this factor structure (for
summary see Friedman et al., 2011), alternative two- (Asmundson et al., 2003), three- (American
Psychiatric Association, 2000), four-(Rademaker et al., 2012; Simms, Watson & Doebbelin,
2002), and five-factor (Elhai et al., 2011) models have been proposed. Of these models, the
dysphoric and numbing models have received the most attention in the literature, have garnered
the most empirical support, and were a primary source of recent changes to the DSM-5 PTSD
criteria. The dysphoric and numbing models identify an internalizing symptom presentation that
is characterized by symptoms related to a reduction in emotional experience and general
emotional distress. The numbing model closely resembles the DSM-IV criteria for PTSD (see
Table 1), with the exception of separating the avoidance symptom cluster into effortful
avoidance (C1-C2), defined as the willful avoidance of thoughts, people, and places, and
emotional numbing (C3-C7). The latter includes amnesia, anhedonia, detachment from others,
2

restricted range of affect, and a sense of foreshortened future. The dysphoria model also includes
this division of the avoidance factor, but combines the numbing symptoms with three arousal
symptoms to create a dysphoric factor. The resulting dysphoric factor is based on the clustering
of these eight symptoms (i.e., D1-D3 and C3-C7) that include the numbing symptoms along with
difficulty sleeping, irritability, and difficulty concentrating. By combining elements of the
avoidance and arousal factor, the dysphoria model also creates an additional two-item
hyperarousal factor comprised of the remaining arousal symptoms (i.e., hypervigilance and an
exaggerated startle response). The authors of the dysphoria model have argued that the clustering
of the dysphoric symptoms is associated with a general distress and dysphoria construct common
to many anxiety and depressive disorders (Simms et al., 2002) whereas the remaining factors are
more characteristic of an anxious traumatic response.
In a recent meta-analysis, the dysphoric model was found to provide marginally superior
fit than the numbing model (Yufic & Sims, 2010). However, other researchers have
demonstrated that although the dysphoric and numbing models differ conceptually and the
overall fit of the dysphoric model has been shown to be marginally superior, the mathematical
difference between these two models hinges on the estimation of the correlation between the
symptoms in the arousal factor and not on the clustering of the dysphoric symptoms (Elhai et al.,
2011; Marshall et al., 2013). The arousal factor in the dysphoric model contains only two
symptoms, whereas the arousal factor in the numbing model contains all five symptoms present
in the DSM-IV arousal criteria. The superiority of the dysphoric model relies on the
underestimation of this two-item correlation in the numbing model and not on the clustering of
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the symptoms in the dysphoric factor (Marshall, 2013). Therefore, each of these models equally
account for the latent PTSD construct, despite their conceptual difference.
Based on the dysphoric and numbing models, a five-factor model has also been posited
(Elhai et al., 2011). This model separates the dysphoric factor into the numbing symptoms (C3C7) and three general dysphoric symptoms (D1-D3) common to many anxiety and depressive
disorders. The five-factor model demonstrated better fit than the dysphoric and numbing models.
The researchers suggested that this was because the five-factor model better accounts for the
separation of fear-based symptoms present in the re-experiencing and the two-item arousal
factors, as well as accounts for the depression-related symptoms represented by the emotional
numbing factor (Elahi et al., 2011).
Despite numerous studies investigating the latent and factor structure of PTSD, the
evidence is still unclear as to whether the cognitive and dysphoric symptoms of PTSD represent
a unique symptom profile necessitating targeted PTSD treatment or whether these symptoms are
attributable to comorbid depression (Moore et al., 2009). Due to the conceptual overlap between
the internalizing symptoms of PTSD and depression, some researchers have suggested the
removal of these symptoms (Brewin, 2009). However, there is increased recognition of the
diverse presentation of PTSD (Friedman et al., 2011) and the contribution of dysphoric and
anhedonic symptoms in predicting the duration, severity, and functional impairment associated
with PTSD (Friedman et al., 2013; Meiser-Stedman et al., 2009; Moser et al., 2007).
Additionally, there is substantial evidence for the presence of distinct maladaptive cognitions
specifically associated with traumatic stress (Friedman et al., 2011; Resick et al., 2009).
Longitudinal evidence has shown a bi-directional relationship between depression and PTSD,
4

suggesting that depressive symptoms may be a core element of a maladaptive traumatic response
(Dekel et al., 2014). Based partially on this evidence a “negative alterations in cognitions and
mood” symptom cluster has been included in the DSM-5 comprised of persistent cognitions and
numbing symptoms (American Psychiatric Association, 2013).
One potential method for resolving these issues is to uncover a factor structure of PTSD
by examining the extensive PTSD treatment literature and underlying mechanism of therapeutic
action. Limited empirical evidence exists that supports efficacious treatment for combat veterans
(Frueh et al., 2007). Data from available treatment studies suggests that the effect sizes of
available psychological treatments are moderate, are associated with high dropout rates, and are
minimally beneficial or ineffective for a substantial portion of patients (Bradly et al., 2005;
Roberts et al., 2009). Given the complex role of both heightened physiological arousal and
cognitive distress in PTSD, two main cognitive-behavioral treatments have emerged from the
PTSD treatment literature. Cognitive Processing Therapy (CPT) and Prolonged Exposure
Therapy (PE) are the most widely studied and supported treatments for PTSD, and are primary
psychological interventions utilized by the Veteran Affairs Health facilities for the treatment of
combat veterans (Foa, Keane, Friedman, & Cohen, 2009). Multiple randomized control trials
(RCTs) and meta-analyses have provided evidence that CPT and PE have relatively equivalent
beneficial outcomes (Foa et al., 2009; Foa, Rothbaum, Riggs, & Murdock, 1991; Resick &
Schnicke, 1992) despite different theoretical mechanisms of change. The Emotion Processing
Theory, underlying PE, posits that repeated exposure to the anxiety-provoking stimuli facilitates
the naturally occurring process of habituation (Foa & Kozak, 1986). This process allows new
learning to occur, resulting in traumatic memories no longer eliciting heightened physiological
5

responses and emotional distress (Foa, Hearst, Dancu, Hembree, & Jaycox, 1994). Utilizing a
different approach, and based on social cognitive theory, CPT attempts to promote recovery
through an examination of the meaning of the traumatic event (Resick & Schnicke, 1992).
Repeated altering of maladaptive cognitions and the integration of the traumatic event into the
patient’s “self-schema” is theorized to reduce the secondary emotions (e.g., depression, guilt,
self-blame) and intrusive recollections associated with PTSD (Resick, Monson, & Chard, 2010).
Although different mechanisms of change are suggested by these theories, empirical
evidence suggests that these changes do not occur in isolation (Gallagher & Resick, 2012; Zalta
et al., 2013). Meta-analytic (Benish, Imel, & Wampold, 2008; Resick et al., 2002) and individual
research studies have shown that, through a yet unidentified mechanism, cognitive changes occur
during PE (Zalta et al., 2013), and that some techniques used in CPT (e.g., writing of traumatic
scenes) have been likened to exposure and habituation. This evidence supports the reduction of
both cognitive and physiological symptoms of PTSD, regardless of treatment type (Gallagher &
Resick, 2012; Resick et al., 2002). Recent empirical evidence suggests that although PE and CPT
both provide beneficial changes in cognitions and physiological arousal, the different underlying
mechanisms of change promote increased recovery in their respective domain (Gallagher &
Resick, 2012). Specifically, Gallagher and Resick found that PE resulted in a decrease in PTSD
symptoms as mediated by habituation, independent of cognitive changes in hopelessness,
whereas CPT resulted in similar decreases in PTSD symptoms, as mediated by greater changes
in hopelessness (Gallagher & Resick, 2012). However, in this study, PE was still shown to
significantly reduce hopelessness, and more recent research has provided further evidence for
adaptive changes in cognitions occurring during PE treatment (Zalta et al., 2013).
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Although these results appear to suggest different changes that may be best utilized by
combining treatments, several studies have explored combining PE with cognitive restructuring
(Foa & Rauch, 2004; Moser, Cahill, & Foa, 2010). Unfortunately, these studies have shown that
this approach did not enhance the efficacy of either treatment. One potential explanation for
these findings may be that different PTSD patients respond to different treatment modalities. For
example, several researchers have suggested that a possible explanation for a patient’s lack of
improvement after PE may be an over-fixation on the meaning of the trauma that interferes with
the habituation process (Tarrier et al., 1999). However, a precise method for separating
individuals with PTSD into distinct categories has proven difficult.
One study providing information relevant to treatment matching in PTSD retrospectively
examined the effects of PE and Cognitive Restructuring (CR), with PTSD patients reporting
higher levels of negative trauma-related cognitions (Moser, Cahil, & Foa, 2010). The results
from this study suggest that individuals receiving the combined treatment fared worse than those
patients receiving PE alone. However, several confounds could explain the results from this
study. Although patients did not differ on initial assessments of PTSD symptom severity, it is
possible that patients who report heightened physiological symptoms coupled with secondary
cognitive symptoms associated with PTSD are experiencing a greater level of overall distress as
compared to patients with primarily physiological symptoms. Additionally, in this particular
study, the length of treatment sessions was identical in each condition despite the addition of
therapy content. As a result, content from the PE condition (e.g., discussions of anxiety) was
sacrificed in order to accommodate CR. Given the absence of dismantling studies in the
literature, essential components of PE may have been removed in this study as research has
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shown that affective labeling is associated with greater gains in exposure therapy (Kircanski,
Leiberman, & Craske, 2012). Additionally, not providing adequate time for CR suggests that
perhaps neither treatment was provided adequately. Despite these methodological limitations, the
findings from numerous studies suggest that PE alone has a beneficial effect on cognitions (Foa
& Rauch, 2004; Gallagher & Resick, 2012; Resick et al., 2013; Zalta et al., 2013), and that this
effect may be a potential mechanism of beneficial therapeutic change (Zalta et al., 2013).
However, the administration of CPT appears to achieve greater changes in these cognitions by
directly addressing them (Gallagher & Resick, 2012; Resick et al., 2013), and combining these
treatments may be contraindicated.
Existing studies point to adjustments in maladaptive cognitions, and the facilitation of
habituation as primary targets of intervention and essential components of achieving desired
treatment outcome (Keane & Barlow, 2002; Resick, 2001). However, treatments targeting these
two mechanisms do not work for all individuals with PTSD (Schnurr et al., 2007), and both CPT
and PE report a significant dropout rate (≈20 percent) (Bryant et al., 2007). The existing
literature indicates that individual characteristics associated with dropout include catastrophic
cognitions and higher avoidance (Bryant et al., 2007). Thus, the perception that these symptoms
are not being targeted or improved upon in treatment may lead an individual to withdraw early
from the intervention.
The empirical evidence summarized above suggests that distinct response patterns to
PTSD therapy may be associated with different underlying mechanisms that may necessitate
targeted treatment. The first step in disentangling the contribution of different trauma types or
maladaptive response patterns is, therefore, to identify a reliable way to detect specific symptom
8

profiles that may respond differently to empirically supported interventions. In response, the
current study conducted a CFA based on mechanisms of beneficial therapeutic change that may
inform treatment matching.
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CHAPTER TWO: METHOD
Participants
Data was collected as part of a Department of Defense-funded RCT that is treating
Operation Enduring Freedom (OEF, Afghanistan) and Operation Iraqi Freedom (OIF) combat
veterans diagnosed with PTSD. Veterans participated in either a 3-week or 17-week treatment
condition that began with a variety of pre-treatment symptom and diagnostic measures.
Participants were paid $50 for completing the pre-treatment assessment. The sample consisted of
both third-party mandated and treatment-seeking veterans. Inclusion criteria required a PTSD
diagnosis confirmed by supervised clinicians. Twenty percent of diagnostic interviews were
randomly selected for Inter-rater reliability analysis. This analysis revealed excellent consistency
on rating CAPS total scores (ICC=.996 ₭=1.00) and PTSD diagnosis (k=1.00). To collect a
representative sample, minimal exclusion criteria were used to derive the original sample.
Participants were only excluded if they had a significant history of cardiac symptoms that could
have potentially interfered with treatment, an acute substance abuse disorder that prevented the
participant from demonstrating two weeks of abstinence, medications that could not be stabilized
for two weeks, or the participant met criteria for antisocial personality disorder. Due to the nature
of the OEF and OIF conflicts resulting in high rates of Traumatic Brain Injury (TBI) (Shively &
Perl, 2012; Vasterling, Verfaellie, & Sullivan, 2009), veterans diagnosed with a TBI were
included in the original sample.
The original sample included 150 OEF/OIF veterans, (139 males; 11 females) between
the ages of 21 and 63 years (MAge= 35.32 SD=9.54). Among the sample, 26% were on active
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duty, 42% reported a history of a TBI diagnosis, and 51.3% received service-connected disability
at the time of pre-assessment. In regards to their service, 61.3% had served in the Army, 26.7%
in the Marines, 6% in the Air Force, 5.3% in the Navy, and 0.7% as Civilian Contractors. For
52% of the veterans in the original sample, high school was their highest level of education,
whereas, 12.7% completed some high school. 25.3% had completed some college, 4.7 % had
received a bachelor’s degree, and 1.3% had a master’s degree. 4% of the sample did not report
their highest level of education. Of the veterans, 55.2% identified as White, 13.4% as
Black/African American, 24.7% as Hispanic, 2% as Asian, 2% as Biracial, and 2.7% identified
as Other. In regards to their relationship status, 33.7% were Single, 43.3% were Married 8.7%
were Separated, 13.6% were Divorced and 0.7% were in a Domestic Partnership.
The original sample included 150 OEF/OIF veterans, (139 males; 11 females) between
the ages of 21 and 63 years (MAge= 35.32 SD=9.54). Among the sample, 26% were on active
duty, 42% reported a history of a TBI diagnosis, and 51.3% received service-connected disability
at the time of pre-assessment. In regards to their service, 61.3% had served in the Army, 26.7%
in the Marines, 6% in the Air Force, 5.3% in the Navy, and 0.7% as Civilian Contractors. For
52% of the veterans in the original sample, high school was their highest level of education,
whereas, 12.7% completed some high school. 25.3% had completed some college, 4.7 % had
received a bachelor’s degree, and 1.3% had a master’s degree. 4% of the sample did not report
their highest level of education. Of the veterans, 55.2% identified as White, 13.4% as
Black/African American, 24.7% as Hispanic, 2% as Asian, 2% as Biracial, and 2.7% identified
as Other. In regards to their relationship status, 33.7% were Single, 43.3% were Married 8.7%
were Separated, 13.6% were Divorced and 0.7% were in a Domestic Partnership.
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Measures
Clinician-Administered PTSD Scale (CAPS)
The CAPS (Blake et al., 1990; Weathers & Litz, 1994) is a 30-item semi-structured interview
that assesses the DSM-IV criteria for PTSD. Additionally, the CAPS includes dual (i.e.,
frequency and severity) ratings of the 17 PTSD symptoms and questions targeting the social and
occupational impairment associated with PTSD. The CAPS interview allows clinicians to gain
additional detail and insight into the patient’s trauma and subsequent impairment in functioning.
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
The SCID-I (First et al, 1996) is a semi-structured clinical diagnostic interview that includes
major DSM-IV-TR Axis I diagnostic classes. The SCID was administered to the original sample
to assess for comorbid diagnoses such as depression, as well as to confirm the diagnosis of
PTSD.
Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II)
The SCID-II Self-Report (First et al., 1997) is a 119-item measure for assessing the 11 Axis II
personality disorders from the DSM-IV-R (4th edition, revised). Specific questions were selected
(see analytic strategy below) that best represented maladaptive cognitions associated with PTSD.
The DSM-5 Negative Cognitions and Mood criteria and the CPT treatment manual were used to
inform the selection of these items. Although the SCID-II is most often used to assess the
occurrence of personality based psychopathology, this self-report measure contains a wealth of
information related to a participant’s clinical presentation. A limited number of items were
drawn from each of the SCID-II categories, and, therefore, the amount of items selected was not
12

sufficient to qualify for a SCID-II personality diagnosis. Additionally, the SCID-II self-report
was designed as a screening measuring and is not recommend for use in isolation to diagnose
personality disorders (SCID-II User’s Guide; First et al., 1997) due to the conceptual overlap
between distress-related Axis-I disorders and personality-based psychopathology.
The Quality of Life Inventory (QOLI)
The QOLI (Frisch et al., 1993) is a 32-item measure assessing the importance and satisfaction of
16 life domains: Health, Self-Esteem, Goals and Values, Money, Work, Play, Learning,
Creativity, Helping, Love, Friends, Children, Relatives, Home, Neighborhood, and Community.
These 16 items are rated on a 3-point Likert scale for importance and a 6-point Likert scale for
satisfaction. The item representing self-esteem was selected to assess the esteem component of
CPT and the maladaptive self-blame cognition.
Hamilton Rating Scale for Depression (HAM_D)
The HAM_D (HAMD; Hamilton, 1959) is a 17-item measure assessing the symptoms of
depression and is one of the most widely used scales to assess depressive symptomatology.
Specific items were selected (see analytic strategy) to differentiate maladaptive cognitions
related to the traumatic event and items related to comorbid depressive symptomatology.
Overall Assessment Strategy

Analytic Strategy
The original sample is thought to be highly representative of a veteran population.
Researchers have recommended the inclusive sampling method implemented in this study to best
generalize research findings to veteran populations (Frueh, Mirabella, & Turner, 1995). The
13

sample size of 150 was supported based on best-practices for Confirmatory Factor Analysis
(CFA) suggesting the practicality of conducting a CFA with lower sample sizes when examining
an established factor structure in a unique population (MacCallum, et al., 1999). The CFA was
conducted using IBM SPSS AMOS 21(Arbuckle, 2006) to perform estimation techniques, fit
indices, and comparative evaluations of competing models. Items from the CAPS assessing
PTSD symptoms were supplemented with selected items from the SCID-II, QOLI, and HAMD.
Many of the existing factor-analytic models examining PTSD have been based on
establishing the underlying structure of the disorder. Although these theoretical models are
essential for establishing diagnostic criteria and uncovering new targets of intervention, the
direct treatment utility of these models is limited. Therefore, the present analysis aimed to build
on aspects of the established dysphoric and numbing models proposed by Simms and colleagues
(2002) and King and colleagues (1998). Additionally, questionnaire items were incorporated to
establish a cognitive subset of symptoms corresponding to the central tenets of CPT (see Table
2) and consistent with DSM-5 negative cognition criteria for PTSD (see Table 3).
The present CFA aimed to construct a model (see Figures 1 & 2) that was based on the
mechanisms of action of PE and CPT interventions with the goal of treatment matching. The
proposed model contained two hypothesized latent variables comprised of cognitive or
physiological symptoms; both stemming from a larger PTSD construct. Although PE and CPT
attribute the occurrence and maintenance of symptoms to different underlying causes (fear
conditioning vs. maladaptive cognitions), some shared symptoms could theoretically result from
either of these causes. Therefore, symptoms shared between the cognitive and hyperarousal
constructs are represented in Figure 1 by three latent variables (e.g., re-experiencing symptoms,
14

anxious arousal, and effortful avoidance) that have been validated in Elhai and colleagues’ fivefactor model (2011). However, other CFA studies have proposed a two factor model that
combines re-experiencing and hyperarousal symptoms (Buckley, Blanchard, & Hickling, 1998).
Therefore, two separate models were examined to test the validity of the shared symptom
hypothesis. The shared symptom model hypothesizes shared symptom clusters (anxious arousal
& re-experiencing symptoms); the specified symptom model identifies these symptoms as part of
the physiological symptom construct.
Previous factor-analytic studies have also validated the distinct factor loadings for
effortful avoidance symptoms demonstrating that criterion C1 (efforts to avoid thoughts,
feelings…associated with the trauma) and C2 (efforts to avoid activities….that arouse
recollections of the trauma) load separately from other, more cognition-based avoidance
strategies. These cognition-based avoidance strategies (C4-C7) are referred to in other models as
emotional numbing, and are therefore clustered under the latent variable of “emotional numbing”
with the omission of C3 (inability to recall important aspects of the trauma). Criterion C3 was
included as an “anxious arousal” shared variable because it has previously demonstrated poor fit
with the emotional numbing construct (King, Leskin, King, & Weathers, 1998), and could
theoretically result from either sustained hyperarousal or rumination on trauma related
cognitions. Previous studies have also demonstrated evidence for memory impairments
associated with pathological anxiety (Boldrini et al., 2005). Therefore, in the specified symptom
model, C3 falls under the physiological symptom cluster.
In addition to emotional numbing, the cognitive symptom construct was based on the
theoretical mechanisms of action for CPT as well as the DSM-5 criteria for negative alterations
15

in cognitions and mood. This construct was comprised of several SCID-II items in addition to
items derived from other measures including the QOLI and HAM_D, which correspond to
symptoms targeted by CPT (e.g., negative beliefs, distorted blame of self and others, guilt). In
CPT treatment, these cognitions are addressed through specific modules targeting concerns over
guilt, self-blame, safety, trust, control, and esteem.
The physiological symptom construct (see Table 4) has also been partially supported in
previous studies examining the dysphoria model which have demonstrated that symptom D4
(hypervigilance) and D5 (exaggerated startle response) load onto a separate hyperarousal
construct. Additionally, these models have also shown that D1 (difficulty falling asleep), D2
(irritability and outburst of anger), and D3 (difficulty concentrating) also load independently
from the main hyperarousal variables. Therefore, theory justified the separation of these
constructs. In addition to the established hyperarousal construct, criterion B5 (physiological
reactivity to exposure cues) was included in the physiological arousal factor as exposure therapy
is theorized to best target this type of conditioned fear response. This symptom is traditionally
subsumed under intrusion/re-experiencing symptom category; however, for the purposes of this
model, it was included as a physiological symptom.
Some researchers have suggested that the cognitive symptoms observed in patients with
PTSD are more attributable to comorbid depression (Brewin et al., 2009), whereas others have
suggested that these cognitive symptoms are unique to PTSD (Friedman et al., 2011). Therefore,
the proposed model also included a latent depression variable that was comprised of four
manifest variables that are more consistent with a depression diagnosis, but are not part of the
DSM-5 criteria for PTSD (e.g., depressed mood, loss of appetite, loss of weight, and
16

psychomotor retardation). The first of these variables was the SCID-I diagnosis of Major
Depressive Disorder (MDD), and the others were symptom-derived from the HAM_D
depression items.
The first phase of the analysis evaluated the fit of the shared symptom model as
compared to the specified symptom treatment matching model to determine the best model for
continued model evaluation. The next phase of the proposed analysis evaluated the validity of
the treatment matching model by comparing it to three additional models. As a primary point of
comparison, the proposed model was first compared to a simplistic model containing all 17
PSTD symptoms with the addition of the cognitive items and no latent variables. The treatment
matching model was then compared to the DSM-IV and DSM-5 models. Other researchers have
employed this method to demonstrate the validity of their model (Simms et al., 2002). In the
second phase of analysis, the proposed model was then compared to four models including
depression with the goal of establishing the role of depression in the occurrence of cognitive
symptoms. The second phase of analysis initially evaluated if the correlation hypothesis depicted
in Figure 5 and 6 between depression and PTSD was accurate. The series of models (Figures 5 to
8) also evaluated the independent nature of the cognitive symptom construct to determine if the
variance in this construct was more attributable to PTSD or comorbid depression.
Data Preparation
The analysis was estimated using Generalized Least Squares (GLS) as this method has
been shown to be robust to smaller sample sizes and non-normal data (Hu & Bentler, 1999).
However, after a simplification of the hypothesized treatment matching model, maximum
likelihood (ML) estimation was also appropriate and reported. Consistent with SEM best
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practices (Hu & Bentler., 1999), model fit was assessed using several fit indices. Model fit was
assessed primarily using the comparative fit index (CFI) and standardized root mean square
residual (SRMR), as both have been shown to be robust to smaller sample sizes (Bentler, 1988).
The root mean square error of approximation (RMSEA) was also examined to assist with
interpretation. Cases with more than 10% missing data were excluded resulting in 3 participants
be excluded from the analysis. The remainder of the missing data was estimated using the series
mean for CAPS, HAM_D and the QOLI and the mean of nearby points for the SCID-II. The
SCID-II nearby points estimation technique was implemented because the grouped dichotomous
item structure of the measures where in questions are grouped to reflect related constructs.
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CHAPTER THREE: RESULTS
Latent variables representing symptom categories (e.g., re-experiencing, effortful
avoidance, emotional numbing) were removed to reduce the complexity of the proposed model.
The removal of these latent variables allowed for a more direct examination of the validity of
physiological and cognitive symptom constructs. A comparison of two proposed models revealed
that fit was similar whether hypothesized shared symptoms were specified uniquely (CFI=.815;
RMSEA=.057; SRMR=.08; Figure 4) or simultaneously (CFI=.816; RMSEA= .057; SRMR=.08;
Figure 3) to the cognitive and physiological symptom constructs. Only effortful avoidance
symptoms (C6 and C7) were shared between constructs in the unique specification model,
whereas emotional numbing symptoms and re-experiencing symptoms were modeled as
indicators of the cognitive construct and physiological construct, respectively. However, since
more specified paths always lead to better model fit, parsimony fit indices were examined to
account for the number of paths drawn. Parsimony fit indices revealed that the unique
specification model (PCFI=.742) demonstrated better fit than the shared symptoms model
(PCFI=.707). As a result, the unique specification model was used for the remainder of model
testing.
The hypothesized treatment matching model was then compared to three well-established
models: a simplistic model containing all 17 PSTD symptoms with the addition of the cognitive
items, the DSM-IV 3-factor model and the DSM-5 4-factor model. The chi square for the
hypothesized treatment matching model was significant (χ2(311)=460.374, p<.001), which
typically indicates poor fit. However, chi square is an absolute fit index that may be overly
sensitive to small differences between the observed and predicted covariance matrices
19

(Tabachnick & Fidell, 2013). Therefore, the standardized root mean square residual (SRMR) and
the root mean square error of approximation RMSEA were also examined. They indicated
marginal (SRMR=.08) and good fit (RMSEA=.057), respectively. Due to the small sample size,
the Generalized Least Squares (GLS) estimation method was also implemented and revealed a
goodness of fit index (GFI) that suggested marginal fit (GFI=.829), whereas RMSEA and SRMR
suggested good fit (RMSEA=.027) and poor fit (.10), respectively. The inconsistency between
these fit indices usually reflects a model requiring additional specification or revision. Overall,
across several estimation techniques and fit indices, the hypothesized treatment matching model
demonstrated marginal fit; however, two measure items did not significantly contribute to the
model. Specifically, the cognitive items judging others harshly (SCID-II_37), believing that most
people are no good (SCID-II _38) and not being able to forgive people for past grievances (SCID
-II_46) did not account for a significant portion of the variance. However, these items did
account for variance in the DSM-5 Model. Compared to alternative models, however, the
treatment matching model demonstrated better fit than the simplistic PTSD model the DSM-IV
model, and the DSM-5 model (See Tables 6 & 7).
Models were also examined to uncover the relationship between PTSD,
depressive symptomatology, and cognitive symptoms. This analysis revealed that models
containing a depressive construct demonstrated equally marginal fit (See Tables 8 & 9)
regardless of correlation or causal hypotheses. Therefore, a statistical comparison of these
models was not conducted.
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CHAPTER FOUR: DISCUSSION
Researchers have begun to acknowledge a diverse range of post-trauma symptoms and
the subsequent impairment associated with multiple types of traumatic events. In particular,
combat soldiers experience multiple types of potentially traumatic events such as direct combat,
hostage situations, and violations of personal moral standards (i.e., moral injury). Recent
evidence suggests that different types of traumatic events may elicit different symptoms profiles
(Stein et al., 2009). Moreover, two theoretically distinct treatments, PE and CPT, have emerged
from the literature as two efficacious methods for treating these symptoms in veterans (Foa,
Keane, Friedman, & Cohen, 2009) and appear to have relatively equivalent outcomes. Our
investigation attempted to validate a treatment matching model that contained factors directly
related to the central mechanisms of action within PE and CPT. The physiological symptom
factor in the proposed model included symptoms (e.g., hyperarousal, flashbacks, physiological
reactivity to exposure cues) theorized to be most amenable to Emotion Processing Theory and
habituation-based treatments such as PE. The cognitive symptom factor included items
representing the DSM-5 PTSD maladaptive cognition criteria (e.g., guilt & negative
expectations) and aligned with social cognition theory as well as therapeutic mechanisms
essential to CPT.
The resulting treatment matching model demonstrated marginal fit; however, multiple fit
indices revealed that our model fit the data better than several established models including the
DSM-IV and DSM-5 models. Furthermore, specific symptom loadings varied in magnitude (See
Tables 10 & 11) whereas physiological (β=.654) and psychological (β=.650) reactivity and
difficulty concentrating (β=.597) demonstrated the best fit with the physiological construct (in
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treatment matching model). The highest loadings for the cognitive construct were items
reflecting a sense of foreshortened future (β=.555), self-esteem (β= -.560) and anhedonia
(β=.613).
Although this study provides some initial support for the treatment matching model and
can be utilized to refine further model testing, there are several limitations worth noting. The first
of these limitations is associated with the items that defined the cognitive symptom construct. In
a recent revision to the DSM criteria for PTSD, several cognitive symptoms were added that
more broadly defines the disorder to include multiple cognitive distortions in addition to
heightened physiological reactivity. Given this recent revision, several cognitive symptoms were
not measured during the ongoing PTSD randomized clinical trial from which data for this
investigation were drawn. As a result, items from other measures (HAM_D, SCID-II) were
extracted instead to best represent these constructs. Although these items did appear to match the
DSM-5 criteria, the items were not specifically related to PTSD nor previously established as
valid measures of trauma-related cognitions. Additionally, several of these items were
dichotomous and may have limited the variance captured by the model.
The conclusions of this study may also be limited by the treatment modalities offered to
our sample. Data from two treatment conditions (3-week & 17-week) were collapsed to obtain
sufficient power for model testing. Examining the samples separately revealed significant
differences in overall PTSD severity as well as multiple individual symptoms representing the
cognitive construct. It is possible that individuals with greater PTSD severity present with a
unique symptom profile not represented by our model. Additionally, the data used for model
testing was gathered from a sample of treatment seeking veterans. It is possible that veterans
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electing to participate in this trial self-selected based on specific symptoms and the perceived
benefits explained to them by study recruiters. Furthermore, individuals with a cognitive based
symptom profile may be less likely to seek out treatment trials due to symptoms such as
anhedonia and detachment from others.
The results of this study also raise interesting questions regarding the co-occurrence of
depression and PTSD. Few conclusions can be drawn due to the marginal fit demonstrated by
these models (Figures 5 through 8). With this in mind, some information can be drawn from
these models to inform future model testing. For example, the models examining a causal
relationship between the depression construct and the cognitive construct demonstrated worse fit
relative to models containing an uninfluenced cognitive construct. Furthermore, the addition of
the depression factor did not significantly reduce the overall model fit, suggesting that comorbid
depressive symptomatology is an important consideration for future model testing. However,
these differences were small and interpreting association within marginal fitting models should
be done with caution. Overall, the overlap of the cognitive criteria within PTSD and depression
remains an open question that requires further investigation.
This is the first study to attempt to devise a model based on therapeutic mechanisms of
action. Based on our findings, future research should continue to refine and develop models for
the purpose of treatment matching. PTSD is an ideal candidate for this technique due to the
development of two theoretically distinct efficacious treatments and need for improved treatment
outcomes. Further research should also continue to uncover the mechanisms of action underlying
these treatments and better incorporate this information to refine and more effectively deliver
existing treatments.
23

APPENDIX A: FIGURES

24

Manifest Variables:
SCID2_34
SCID2_35
SCID2_36
SCID2_37
SCID2_38
SCID2_39
SCID2_40
SCID2_46
QOLI_4
HAMD_2

Do you believe that you are basically an inadequate person and often don't feel good about yourself?
Do you often put yourself down?
Do you keep thinking about bad things that have happened in the past or worry about bad things that might happen in the future?
Do you often judge others harshly and easily find fault with them?
Do you think that most people are basically no good?
Do you almost always expect things to turn out badly?
Do you often feel guilty about things you have or haven't done?
Are there many people you can’t forgive because they did or said something to you a long time ago?
How satisfied are you with your self-esteem?
Feelings of Guilt: Do you often brood about past mistakes?
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CAPS_1
CAPS_2
CAPS_3
CAPS_4
CAPS_5
CAPS_6
CAPS_7
CAPS_8
CAPS_9
CAPS_ 10
CAPS_11
CAPS_12
CAPS_13
CAPS_14
CAPS_15
CAPS_16
CAPS_17

Intrusive Recollections
Distressing Dreams
Acting or feeling as if the event were recurring
Psychological distress at exposure cues
Physiological reactivity on exposure to cues
Avoidance of thoughts or feelings
Avoidance of activities, places, or people
Inability to recall important aspects of the trauma
Diminished interest in activities
Detachment & Estrangement
Restricted range of affect
Sense of Foreshortened Future
Difficulty falling or staying asleep
Irritability or outbursts of anger
Difficulty Concentrating
Hypervigilance
Exaggerated Startle Response

Figure 1. Hypothesized shared symptom treatment-matching model with manifest variables
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Figure 2. Hypothesized specified symptom treatment-matching model
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Figure 3. Shared Symptom Model
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Figure 4. Specifified Symptom Model
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Manifest Variables (Depression):
SCID_I
HAMD_1
HAMD_8
HAMD_12
HAMD_16

MDD diagnosis from SCID I
Depressed Mood: Sadness, hopeless, helpless, worthless
Retardation: Slowness of thought and Speech: impaired ability to concentrate: decreased motor activity
Somatic Symptoms Gastro-intestinal (Loss of Appetite)
Loss of Weight

Figure 5. PTSD Correlated with Depression Model with Manifest Variables
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Figure 6. PTSD Predicting Depression Model
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Figure 7.PTSD Correlated with Depression Predicting Cognitive Symptoms Model
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Figure 8. PTSD Predicting Depression Predicting Cognitive Symptoms Model
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Table 1. Changes to DSM Criteria for PTSD

DSM-5 Criteria for PTSD
B1. Intrusive thoughts
B2. Nightmares
B3. Re-living trauma
B4. Emotional cue reactivity
B5. Physiological cue reactivity
C1. Avoidance of thoughts
C2.Avoidance of reminders

D1. Trauma related amnesia
D2. Persistent negative beliefs about the world
D3. Persistent distorted blame
D4. Persistent trauma-related emotions
D5. Loss of interest
D6. Feeling detached
D7. Constricted affect
E1. Irritable or aggressive behavior
E2. Self-destructive or reckless behavior
E3. Hypervigilance
E4. Exaggerated startle response
E5. Problems in concentration
E6. Sleep disturbance

DSM-IV Criteria for PTSD
B1. Intrusive thoughts
B2. Nightmares
B3. Re-living trauma
B4. Emotional cue reactivity
B5. Physiological cue reactivity
C1. Avoidance of thoughts
C2. Avoidance of reminders
C3. Trauma related amnesia
C4. Loss of interest
C5. Feeling detached
C6. Constricted affect
C7. Hopelessness
D1. Difficulty sleeping
D2. Irritability/anger
D3. Difficulty concentrating
D4. Overly alert
D5. Easily startled
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Table 2. Measure items that reflect CPT Treatment Themes

Central Themes in CPT

Items from Measures
Do you often feel guilty about things you have or haven't done?
(scid2_40)

Self-blame/guilt
Feelings of Guilt: Do you often brood about past mistakes?(HAMD_ 2)
Sense of foreshortened future ( CAPS_C12)
Safety
Do you keep thinking about bad things that have happened in the past
or worry about bad things that might happen in the future? (scid2_36)
Trust

Do you find it hard to be open, even with people you are close to?
(scid2_3)
Detachment & Estrangement (CAPS_C10)
Do you keep thinking about bad things that have happened in the past
or worry about bad things that might happen in the future? (scid2_36)

Control
Do you almost always expect things to turn out badly? (scid2_39)

Esteem

Intimacy

Is it hard for you to do simple or routine things for yourself?
(HAMD_23)
How satisfied are you with your self-esteem? (QOLI_4)
How do the problems you have affect your self-esteem; how do you
feel about yourself? (HAMD_24)
Do you believe that you’re not as good, as smart, or as attractive as
most people (scid2_6))
Do you believe that you are basically an inadequate person and often
don't feel good about yourself? (scid2_34)
Detachment & Estrangement (CAPS_C10)
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Table 3. Basis for Cognitive Variable Items Selection.

DSM-5: Criterion D:
Negative alterations in cognitions and
mood that began or worsened after the
traumatic event.

1. Inability to recall key features of
the traumatic event (usually
dissociative amnesia; not due to
head injury, alcohol, or drugs).

Items from Measures

Inability to recall important aspects of trauma (CAPS_8)

Do you believe that you are basically an inadequate
person and often don't feel good about yourself?
(scid2_34)
Do you often put yourself down? (scid2_35)
2. Persistent (and often distorted)
Do you keep thinking about bad things that have
negative beliefs and expectations happened in the past or worry about bad things that
about oneself or the world (e.g., "I might happen in the future? (scid2_36)
am bad," "The world is
Do you often judge others harshly and easily find fault
completely dangerous").
with them? (scid2_37)
Do you think that most people are basically no good?
(scid2_38)
Do you almost always expect things to turn out badly?
(scid2_39)
3. Persistent distorted blame of self or
others for causing the traumatic
event or for resulting consequences.
4. Persistent negative trauma-related
emotions (e.g., fear, horror, anger,
guilt, or shame).
5. Markedly diminished interest in
(pre-traumatic) significant
activities.
6. Feeling alienated from others (e.g.,
detachment or estrangement).
7. Constricted affect: persistent
inability to experience positive
emotions.

Are there many people you can’t forgive because they
did or said something to you a long time ago? (scid2_46)
How satisfied are you with your self-esteem? (QOLI_4)
Do you often feel guilty about things you have or haven't
done? (scid2_40)
Feelings of Guilt: Do you often brood about past
mistakes? (HAMD_2)
Diminished interest in activities (CAPS_ 9)
Detachment & Estrangement (CAPS_ 10)
Restricted range of affect (CAPS_11)
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Table 4. Items Selected for Arousal Variables

Physiological Reactivity
Phys. Reactivity on exposure cues (CAPS_B5)

Hyperarousal
Hypervigilance (CAPS_D4)
Exaggerated startle response (CAPS_D5)
Problems in concentration (CAPS_D3)

Table 5.. Items Selected for Depression Variables

Depression Diagnosis
Major Depression Diagnosis, Current (SCID-I)

Additional Depressive S(x)
Depressed Mood (HAMD_1)
Loss of Appetite (HAMD_12)
Loss of Weight (HAMD_16)
Psychomotor Retardation (HAMD_8)

Table 6. ML Fit Indices for Model Comparison of Treatment Matching Model

Model
χ2
χ2 sig
df RMSEA CFI
AIC
BCC SRMR
Hypothesized
460.374 <.001 311
.057 .815 648.374 691.878 .08
Simplistic
627.029 <.001 324
.079 .625 789.029 826.516 .09
DSM-IV
267.983 <.001 117
.093 .736 373.983 388.548 .10
DSM-5
628.203 <.001 267
.095 .520 794.203 829.292 .14
Note. df = degrees of freedom; RMSEA = Root Mean Square of Approximation; CFI =
Comparative Fit Index; AIC = Akaike Information Criterion; BCC= Browne-Cudeck Criterion;
SRMR= Standardized Root Mean Square Residual.
Table 7. GLS Fit Indices for Model Comparison of Treatment Matching Model

Model
χ2
χ2 sig
df RMSEA GFI
AIC
BCC SRMR
Hypothesized
354.154 <.001 311
.031 .824 488.154 519.162 .11
Simplistic
421.066 <.001 324
.045 .791 529.066 554.058 .13
DSM-IV
204.894 <.001 119
.070 .828 823.044 881.574 .22
DSM-5
322.170
<.02 267
.037 .827 438.170 462.691 .18
Note. df = degrees of freedom; RMSEA = Root Mean Square of Approximation; CFI =
Comparative Fit Index; AIC = Akaike Information Criterion; BCC= Browne-Cudeck Criterion;
SRMR= Standardized Root Mean Square Residual

38

Table 8. ML Fit Indices for Models Examining PTSD and Depression

Model
χ2
χ2 sig df RMSEA CFI
AIC
BCC SRMR
Correlated Dep.
584.604 <.001 419
.052
.823 800.681 859.681
.08
Corr. Dep/Predict.Cog.
609.044 <.001 420
.055
.798 823.044 881.574
.09
Predict. Dep.
585.573 <.001 420
.051
.823 799.573 858.103
.08
Predict Dep./Predict. Cog. 609.269 <.001 421
.055
.799 821.269 879.252
.09
Note. df = degrees of freedom; RMSEA = Root Mean Square of Approximation; CFI = Comparative
Fit Index; AIC = Akaike Information Criterion; BCC= Browne-Cudeck Criterion; SRMR=
Standardized Root Mean Square Residual.
Table 9. GLS Fit Indices for Models Examining PTSD and Depression

Model
χ2
χ2 sig
df RMSEA GFI
AIC
BCC SRMR
Correlated Dep.
452.359
.126
419 .023
.804 606.359 648.479 .11
Corr. Dep/Predict.Cog.
454.710
.117
420 .055
.798 606.710 648.283 .15
Predict. Dep.
452.657
.131
420 .023
.803 604.657 646.229 .14
Predict Dep./Predict. Cog. 456.477
.113
421 .024
.802 606.477 647.503 .16
Note. df = degrees of freedom; RMSEA = Root Mean Square of Approximation; CFI = Comparative
Fit Index; AIC = Akaike Information Criterion; BCC=Browne-Cudeck Criterion; SRMR=
Standardized Root Mean Square Residual.
Table 10. Treatment Matching Model: Physiological Symptom Loadings

Re-Experiencing Symptoms
Intrusive Recollections (CAPS_1)
Distressing Dreams (CAPS_2)
Acting/Feeling Recurring (CAPS_3)
Psychological Reactivity (CAPS_4)
Anxious Arousal Symptoms
Inability to Recall (CAPS_8)
Difficulty Sleeping(CAPS_13)
Irritability/Anger (CAPS_14)
Difficulty Concentrating (CAPS_15)
Hyper-Arousal Symptoms
Physiological Reactivity (CAPS_5)
Hypervigilance (CAPS_16)
Exaggerated Startle Response(CAPS_17)
Avoidance Physiological Symptoms
Avoidance Thoughts (CAPS_6)
Avoidance Places/Activities (CAPS_7)
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β

Pvalue

.597
.400
.488
.650

<.001
<.001
<.001
<.001

.597
.301
.450
.582

.035
.003
<.001
<.001

.654
.434
.454

<.001
<.001
-

.416
.190

..077
.173

Table 11. Treatment Matching Model: Cognitive Symptom Loadings

Negative Belief Symptoms
Anhedonia (CAPS_9)
Detachment (CAPS_10)
Restricted Affect (CAPS_11)
Sense of Foreshortened Future(CAPS_12)
Inadequate Person (SCID II_34)
Often Put Self Down (SCID II_35)
Preocc. with Past/Future Neg Events (SCID II_36)
Judge Others Harshly (SCID II_37)
Most people No Good (SCID II_38)
Expec. Neg. Outcomes (SCID II_39)
Distorted Blame Symptoms
Can’t Forgive Others (SCID II_46)
Satisfaction with Self-Esteem (QOLI4_4)
Guilt Symptoms
Often Feeling Guilty (SCID II_40)
Guilt for Past Mistakes (HAMD_2)
Avoidance: Cognitive Symptoms
Avoidance Thoughts (CAPS_6)
Avoidance Places/Activities (CAPS_7)
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β

Pvalue

.613
.511
.312
.555
.445
.266
.306
.108
.141
.315

.002
.001
.010
<.001
.002
.020
.011
.260
.154
.009

.133
-.560

.174
<.001

.314
.339

.010
-

.149
.418

.308
.091
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